Abstract
Introduction:
Zika virus (ZIKV) is a mosquito-borne arbovirus. Maternal infection may cause severe complications such as neonatal microcephaly and neurological defects. To date, there is no clinically approved vaccine or specific drug against ZIKV infection. The host calcium-binding protein, S100A6, is a member of S100 protein family, regulates various cellular processes, and has been recognized as a host-dependent factor for Flavivirus infection.
Methods:
S100A6 expression in host cells after ZIKV infection was detected by western blotting (WB). The effects of host S100A6 on ZIKV replication as indicated by the RNA and protein levels of nonstructural protein 3 (NS3) were detected by qRT-PCR, plaque assay, immunofluorescence assay (IFA), and WB respectively. The interaction and co-localization of S100A6 with NS3 were examined through co-immunoprecipitation (Co-IP) and IFA. Proteasome inhibitor and lysosomal acidification inhibitor were used to explore the degradation pathway of NS3 mediated by S100A6.
Results:
ZIKV infection induced a dose- and time-dependent increase in host S100A6 expression. Overexpression of S100A6 in HeLa cells did not affect ZIKV binding or entry into host cells but significantly inhibited viral replication. Conversely, S100A6 knockdown led to a significant increase in ZIKV replication. Moreover, S100A6 was found binding to ZIKV-NS3, leading to NS3 degradation without affecting genome copies. The use of lysosomal acidification inhibitor NH4Cl significantly reversed S100A6-mediated downregulation of NS3 protein levels, suggesting that S100A6 degrades NS3 via the lysosomal pathway.
Conclusion:
ZIKV infection upregulated host S100A6, which acted as an anti-infection factor by specifically targeting ZIKV-NS3 for degradation, thereby inhibiting viral replication. These findings provide insights into a potential mechanism of host resistance to ZIKV infection and enhance our understanding of the ZIKV-host interaction.
1 Introduction
In this decade, Zika virus (ZIKV) disease outbreaks in many countries and regions with large-scale ZIKV infections. In 2016, the World Health Organization (WHO) declared ZIKV infection a Public Health Emergency of International Concern (PHEIC) (). Infection in pregnant women may cause serious complications in fetus and newborns, such as neonatal microcephaly, congenital malformations, and neurological defects, while adults may suffer from serious complications including Guillain-Barre syndrome, meningitis, and retinopathy (; ; ). With the increase of international travel and commercial exchanges around the world, the global spread of ZIKV has accelerated, posing a major threat to human health. On the other hand, no clinically approved specific vaccine or drug is available for treating ZIKV infection (). Therefore, understanding the pathogenesis and host-virus interaction of ZIKV is urgent.
Zika virus (ZIKV) is an arbovirus transmitted by mosquitoes. Similar to other flaviviruses, ZIKV is a spherical enveloped virus with a diameter of about 50 nm (). Its genome is a positive-sense single-stranded RNA of about 10.7 kb in length, encoding a single polyprotein. After processing and cleavage by both host and viral protease, it produces three structural proteins C, prM/M and E, and seven non-structural proteins NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (). Viral structural proteins form the viral particles, and non-structural proteins contribute to viral genome replication and packaging, as well as to the regulation of host cells to support viral infection (; ). NS3 is a multifunctional enzyme with a protease domain at the N-terminus and a helicase domain at the C-terminus (). The activity of NS3 protease requires NS2B as a co-factor to cleave ZIKV polyprotein, indirectly responsible for virus assembly and replication (). The NS3 helicase domain is necessary for resolving the double-stranded RNA formed during viral gene synthesis ().
The S100 protein family is a major subgroup of calcium-binding proteins, with 25 known members whose sequences and structures are highly conserved. They regulate a variety of cellular processes and functions (; ; ). S100A6 is expressed in different mammalian cells, tissues and several tumors, including neural, reproductive and placental tissues, which exhibits significant overlap with ZIKV target sites (; ; ). S100A6 is involved in regulating numerous cellular functions, such as cell proliferation, apoptosis, cytoskeleton dynamics, and cell response to different stress factors (; , ; ; ; ). Studies have found that S100A6 is upregulated in response to various stimuli, such as oxidative stress, arsenite exposure and viral infection (; , ). Intracellular viruses rely on host-related proteins for replication. S100A6 protein has been identified as a host-dependent factor for Flavivirus infection (). Studies have reported that S100A6 can inhibit hepatitis C virus (HCV) replication (), and S100A9 can suppress highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) replication (). Given S100A6’s potential antiviral functions, its multifaceted roles in cellular regulation, and expression overlap with ZIKV target tissues, we prioritized it as a candidate host factor for mechanistic characterization of ZIKV infection.
In this study, we found that the expression level of host protein S100A6 was upregulated after ZIKV infection. As a host restriction factor of ZIKV, S100A6 inhibited viral replication and played an antiviral role through binding and degrading the viral NS3 protein.
2 Materials and methods
2.1 Cell culture and virus
HeLa, BHK-21, and COS7 cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in Dulbecco’s Modified Eagles Medium (DMEM; Gibco/Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco/Invitrogen) and 1% Penicillin-Streptomycin (Gibco/Invitrogen) at 37°C and 5% CO2. Aedes albopictus C6/36 cells (ATCC) were maintained in Roswell Park Memorial Institute 1640 medium (RPMI 1640; Gibco/Invitrogen) supplemented with 10% FBS and 1% Penicillin-Streptomycin at 28°C. The Zika Virus strain Z16006 (GeneBank: no. KU955589.1) was kindly provided by the Institute of Microbiology, Guangdong Provincial Center for Disease Control and Prevention, and was propagated in C6/36 cells.
2.2 Plasmids
The ZIKV NS3 was cloned into pcDNA3.1(+) vector using a forward primer containing a KpnI restriction site and a reverse primer containing an XbaI restriction site, with a 3×FLAG tag fused at the C-terminal (The primers were listed in Supplementary Table 1). Complementary DNA (cDNA) was obtained by reverse transcription of RNA from the HeLa cells infected with ZIKV and used as the template for PCR amplification of ZIKV NS3 gene fragment. The amplified product was digested with restriction enzymes, ligated into the plasmid vector, and used to construct the recombinant expression plasmid. The resulting recombinant plasmids were confirmed by DNA sequencing (Tsingke Biotechnology, Beijing, China). The pcDNA3.1(+)-S100A6-HA and pcDNA3.1(+)-S100A6-TurboID-HA plasmids were previously constructed () and stored in our laboratory at −20°C.
2.3 Antibodies and chemicals
The antibodies used in this study were anti-β-Actin antibody (Abcam, Cambridge, UK, Cat# ab179467), anti-ZIKV NS3 antibody (Genetex, CA, USA, Cat# GTX133309), anti-ZIKV E antibody (Genetex, CA, USA, Cat# GTX133314), anti-S100 alpha 6 antibody (Selleck, Houston, TX, USA, Cat# A5890), anti-HA antibody (Cell Signaling Technology, Boston, MA, USA, Cat# 3724), anti-FLAG M2 antibody (Sigma, St. Louis, MO, USA, Cat# F1804), goat anti-mouse IgG-HRP (ABclonal, Wuhan, China, Cat# AS003), goat anti-rabbit IgG-HRP (Abclonal, Wuhan, China, Cat# AS014), Alexa Fluor 594 goat anti-rabbit IgG (Invitrogen, Carlsbad, CA, USA, Cat# A32740), Alexa Fluor 488 goat anti-mouse IgG (Invitrogen, Carlsbad, CA, USA, Cat# A11001). The antibodies were used following the manufacturers’ guidance.
Proteasome inhibitor MG132 (APExBIO, Houston, TX, USA) was diluted in DMSO and added to the cell culture medium to a final concentration of 10 μM. Similarly, Lysosomal acidification inhibitor NH4Cl (aladdin, Shanghai, China) was diluted in sterile water and added to the cell culture medium to a final concentration of 30 mM.
2.4 Western blotting (WB)
Cells were collected and lysed on ice for 30 minutes using cell lysis buffer (Beyotime, Shanghai, China) containing 1mM phenylmethanesulfonyl fluoride (PMSF, Dingguo, China). After centrifugation at 14000×g, 4°C for 10 minutes, the supernatant was collected and the concentration was measured by bicinchoninic acid (BCA) method. For the S100A6-siRNA experiments, 100 μg of total protein was used, while for the other experiments, 50 μg of total protein was taken. The samples were then diluted in 6 × loading buffer, boiled for 10 minutes, then quickly placed in ice water. After a brief spin, the protein samples were loaded onto 10% or 15% SDS-PAGE gels for separation, and subsequently transferred to polyvinylidene fluoride (PVDF) membrane (Bio-Rad, Hercules, CA, USA). The membrane was blocked in 5% bovine serum albumin (BSA) dissolved in TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.4) in a 37°C shaker for two hours, and then incubated with the primary antibody at 4°C overnight. After washing three times with TBST, the membrane was incubated with an HRP-labeled secondary antibody at 37°C for two hours. Finally, the protein bands were visualized using Clarity Western ECL Substrate (Bio-Rad) and photographed with a ChemiDoc Touch Imaging System (Bio-Rad).
2.5 RNA isolation and quantitative reverse transcription PCR (qRT-PCR)
The ZIKV copies, the knockdown and overexpression efficiency of S100A6, and the NS3 RNA copies were detected by qRT-PCR. Total RNA was isolated using TRIzol Reagent (Invitrogen) and the viral RNA in the supernatant of cell cultures was extracted according to the instructions of EasyPure Viral DNA/RNA Kit (TransGen, Beijing, China). Then the RNAs was reverse-transcribed to cDNAs using HiScript All-in-one RT SuperMix (Vazyme, Nanjing, China). The cDNA was subjected to quantitative PCR using Hieff qPCR SYBR Green Master Mix (Low Rox; Yeasen, Shanghai, China) on QuantStudio 6 real-time PCR system. The S100A6 transcript and NS3 RNA levels were normalized to the transcript level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), using comparative Ct method. Absolute quantification for ZIKV copies were implemented by comparison to a standard curve. The fragment corresponding to nucleotides (10,409 to 10,554) of ZIKV (Z16006) was used as an amplification target. Standard curves were prepared using 10-fold serial dilutions of known quantities of ZIKV fragment. All assays were performed in triplicate. The primers used to amplify the target genes are listed in Supplementary Table 2.
2.6 Viral binding and entry assay
HeLa cells were grown in a 12-well plate to about 70% confluence, and then transfected with pcDNA3.1(+)-S100A6-HA or control plasmid for 24 hours, using Lipofectamine 3000 Reagent (Invitrogen, USA) following the manufacturer’s instruction. For the virus binding assay, the cells were then infected with ZIKV at an MOI of 10 and incubated at 4°C for 1 hour. After the supernatant was discarded, the cells were washed with phosphate buffered saline (PBS) for three times. The cells were harvested and total RNA was extracted by TRIzol and the amount of the viral RNA was determined by qRT-PCR. For the entry assay, after one hour of ZIKV binding at 4°C, the cells were washed with PBS and incubated at 37°C for additional 1 hour. Subsequently, the supernatant was discarded and the cells were harvested following washing with PBS for three times. TRIzol was used to extract total RNA, and qRT-PCR was used to detect the effect of S100A6 on ZIKV entry. The efficiency of S100A6 overexpression was verified by WB.
2.7 plaque assay
BHK cells were seeded in 12-well plates until they reached approximately 70% confluency, and were transfected with either 3.0 ug siRNA-NC or siRNA-S100A6 per well for 24hours. Following transfection, cells were infected with ZIKV at an MOI of 0.1 and incubated for 5 or 10 days. The cells were then fixed in 10% paraformaldehyde for 5 min, stained with 0.1% crystal violet for 30min, followed by washing with PBS for 3 times. After that, the plaques on the plate bottom were photgraphed under a light microscope with 100× or 40× magnification.
2.8 Immunofluorescence assay
BHK-21 cells were grown on coverslips in a 12-well plate to about 70% confluence, and then transfected with 1 μg of plasmids using Lipofectamine 3000 Reagent (Invitrogen) following the manufacturer’s instruction for 24 hours. The cells were separated into two groups, and then infected with ZIKV for 24 hours or left uninfected for control. Afterward, cell cultures were aspirated, and cells were fixed and permeabilized with 100% precooled methanol for 8 minutes at −20°C. Then the methanol was aspirated and the cells were blocked with 10% BSA dissolved in PBS for one hour at room temperature.
After aspiration of the blocking buffer, the coverslips were incubated with the primary antibody at 4°C overnight, at the recommended concentration diluted in 10% BSA according to the manufacturer’s instruction. After washing three times with PBS, the coverslips were incubated with Alexa Fluor 594 goat anti-rabbit IgG (1:1500, Invitrogen) and/or Alexa Fluor488 goat anti-mouse IgG (1:1500, Invitrogen), diluted in 10% BSA for one hour at room temperature. Subsequently, the coverslips were washed with PBS for three times, rinsed with ddH2O and mounted with 4’,6-diamidino-2-phenylindole (DAPI) Fluoromount-G (Southern Biotech, USA). The samples were visualized and photographed using a fluorescence microscope (Nikon, Tokyo, Japan). Ten fields of view were randomly selected from the up, down, left, right and middle sections of each coverslip, and the total number of cells and the number of ZIKV positive cells were counted using Image J software. The virus infection rates of the two groups were calculated and compared.
2.9 Co-immunoprecipitation
HeLa cells were grown in T25 flasks to 70% confluence, and then, each flask was transfected with 3.0 µg pcDNA3.1(+)-S100A6-TurboID-HA or control plasmid for 24 hours using Lipofectamine 3000 Reagent (Invitrogen), following the manufacturer’s instruction. Afterward, the medium was replaced with DMEM containing 160 μM D-Biotin (Sigma-Aldrich, St. Louis, MO, USA) or no D-biotn supplemented, and the cells were infected with ZIKV at an MOI of 1, or left uninfected for another 24 hours. Then the cells were washed with PBS for three times, and lysed with cell lysis buffer (Beyotime) containing 1 mM phenylmethanesulfonyl fluoride (PMSF). Cell lysates were centrifuged at 14,000×g, 4°C for 10 minutes, and the supernatant was collected and incubated with Streptavidin magnetic beads (Thermo Fisher, Waltham, MA,USA) at 4°C overnight with gentle rotation. The beads were collected with a magnetic stand to remove the supernatant, and then, 500 μl precooled Washing Buffer (TBST, 0.1% Tween 20) was added and mixed gently with the beads. After washing three times, the magnetic beads were collected and resuspended in 50 μl PBS and 10 μl 6 × SDS loading buffer. The samples were boiled for 5 minutes and subjected to WB detection.
2.10 Statistical analysis
Statistical analysis was performed using GraphPad Prism 9 (GraphPad Software Inc., San Diego, CA, USA). A two-tailed unpaired Student’s t test was used to compare differences between each group, and one-way Analysis of Variance (ANOVA) with Tukey’s multiple comparisons test was used to compare differences among multiple groups. P < 0.05 was considered statistically significant. Data were represented as mean ± SEM, and all experiments were repeated at least three times.
3 Result
3.1 ZIKV infection upregulated S100A6 levels in host cells
HeLa cells were infected with ZIKV at a multiplicity of infection (MOI) of 1 for 0 h, 6 h, 12 h, 24 h and 48 h, respectively. Cells were collected at the corresponding time points, and the expression of S100A6 was detected. The results showed that the S100A6 expression in ZIKV-infected cells was significantly increased. With the prolongation of infection time, the level of S100A6 increased in a time-dependent manner (Figures 1A, B). The faint NS3 signal observed in the Mock group represents background due to non-specific antibody binding. Subsequently, S100A6 levels were detected 24 hours post infection (hpi) with ZIKV at MOIs of 0, 0.1, 1 and 5 in HeLa cells. It was found that S100A6 expression was significantly upregulated with increasing MOIs in a dose-dependent manner (Figures 1C, D). These results demonstrated that ZIKV infection upregulated S100A6 protein levels in host cells, suggesting that S100A6 may be involved in the regulation of ZIKV infection.
Figure 1
3.2 S100A6 did not regulate ZIKV binding and entry into host cells
Given the increased expression of host S100A6 protein following ZIKV infection, we hypothesized that S100A6 might regulate the life cycle of ZIKV. The entire life cycle of ZIKV requires the interaction between viral and host proteins. During ZIKV infection, the attachment of viral envelope protein E to host receptors mediates its internalization into the host cell (). Following the fusion of the virus membrane protein with host endosomal membrane, the viral genome is released into the cytoplasm to initiate viral genome replication and particle assembly.
To investigate whether S100A6 affects ZIKV’s binding and entry into host cells, HeLa cells were transfected with or without the pcDNA3.1(+)-S100A6-HA plasmid. To evaluate the impact of S100A6 on virus binding, cells were infected with ZIKV at 4°C for 1 h, washed three times with PBS and then harvested for qRT-PCR (Figure 2A). To determine whether S100A6 affected the virus entry, the HeLa cells were infected with ZIKV at 4°C for 1 h, then the cell culture medium was replaced with fresh medium, and the cells were incubated at 37°C for the internalization of the binding viruses (Figure 2B). The overexpression of the S100A6 protein was verified by WB (Figure 2C). There was no significant difference in viral copy number between the S100A6 overexpression group and the control group (Figures 2A, B), indicating that S100A6 did not affect virus binding and entry into cells.
Figure 2
3.3 Host S100A6 inhibited ZIKV replication
Since S100A6 did not affect the binding and entry of ZIKV into host cells, we next explored whether it affected virus replication. RNAi was performed in HeLa cells to inhibit S100A6 expression, after which virus replication was detected. HeLa cells were transfected with si-S100A6 and si-NC for 24 hours, then infected with ZIKV for another 24 hours before being harvested for WB and qRT-PCR. The results showed that S100A6 expression level and transcription level were significantly reduced, confirming successful knockdown (Figures 3A, B). In cells transfected with si-NC, ZIKV infection increased S100A6 mRNA levels, which is consistent with the upregulation of S100A6 protein expression observed in Figure 1. After the knockdown of S100A6, the copy number of ZIKV in both the cell lysates and cell culture supernatant significantly increased (Figures 3C, D), suggesting that host S100A6 plays a role in inhibiting ZIKV replication.
Figure 3
To further verify this, we performed plaque assays. At 5 days post infection (dpi), distinct patterns of cytopathic cell foci formation were observed across groups. Specifically, the si-S100A6 + ZIKV group exhibited the most pronounced foci, followed by the siRNA-NC + ZIKV group. No cytopathic foci were detected in the uninfected controls (siRNA-NC - ZIKV and si-S100A6 - ZIKV) (Figure 4A). At 10 dpi, the plaques formed in siRNA-S100A6 transfected cells were significantly larger than those in siRNA-NC transfected cells (Figures 4B, C).
Figure 4
Given that knockdown of S100A6 expression in host cells would lead to increased viral replication, to further explore the effect of S100A6 on viral replication, the pcDNA3.1-S100A6-HA plasmid was transfected into COS-7 cells, which were subsequently infected with ZIKV. S100A6 overexpression in cells was verified by WB with anti-HA antibody (Figure 5C), and ZIKV replication was detected by qRT-PCR. The copy numbers of ZIKV in both cell lysates and cell culture supernatants were significantly decreased after S100A6 overexpression (Figures 5A, B). We further confirmed the inhibitory effect of S100A6 on viral replication in BHK-21 cells by IFA. S100A6 overexpression was verified by WB with anti-HA antibody (Figure 5F). The nucleus was stained with DAPI (blue) and the virus was stained with a ZIKV E protein antibody (red). The total number of cells and ZIKV positive cells were counted by ImageJ software, and virus infection rates were calculated and compared. ZIKV infection rate in the S100A6 overexpression group was significantly lower than that in the control group (Figures 5D, E), consistent with the qRT-PCR results. These results further confirmed that the host protein S100A6 played a role in inhibiting ZIKV replication.
Figure 5
3.4 Host S100A6 promoted NS3 degradation
NS3 is an essential protein for ZIKV replication. In our previous experiments, we found that S100A6 knockdown in HeLa cells resulted in a significantly higher NS3 protein level compared to the control group (Figure 3B). Conversely, overexpression of S100A6 led to a significant downregulation of the viral protein NS3 (Figures 5C, F). Furthermore, HeLa cells were transfected with a gradient of S100A6-HA plasmid and then infected with ZIKV for 24 hours. As S100A6 protein expression increased, ZIKV copies decreased significantly in a dose-dependent manner (Figure 5A). Meanwhile, we also found that the level of ZIKV NS3 protein and ZIKV genome copies decreased significantly with the increase of S100A6 (Figures 6A, B).
Figure 6
Therefore, we hypothesized that S100A6 might inhibit viral replication through its effect on the NS3 protein. We further constructed the pcDNA3.1(+)-NS3-FLAG plasmid, and co-transfected it with pcDNA3.1(+)-S100A6-HA into HeLa cells. It was found that the exogenous NS3 protein level decreased with an increased amount of S100A6 (Figures 6C, D), indicating that ZIKV NS3 levels were negatively correlated with S100A6 protein amounts and that S100A6 promotes the degradation of ZIKV NS3.
3.5 S100A6 degraded NS3 protein through the lysosomal pathway
S100A6 downregulated the NS3 protein level, but it was not clear whether this was regulated at RNA or protein level. We overexpressed S100A6 in HeLa cells, then infected them with ZIKV(Figures 7A, B), or simultaneously overexpressed both S100A6 and NS3(Figures 7C, D). We found that the protein level of NS3 was significantly decreased compared to the control group without S100A6 expression in both conditions (Figures 7B, D). However, the genome copy (represented by NS3-RNA copy), as detected by qRT-PCR, was not significantly different from the control group (Figures 7A, C), indicating that the downregulation of NS3 protein level by S100A6 occurred at the post-translational level rather than the RNA level.
Figure 7
In eukaryotic cells, proteins are mainly degraded through the ubiquitin-proteasome pathway and lysosome pathway. To explore which pathway S100A6 utilized to degrade NS3, we co-expressed S100A6-HA and NS3-FLAG in HeLa cells. After 36 hours of transfection, the cells were treated with either the proteasome inhibitor MG132 or the lysosomal acidification inhibitor NH4Cl for 12 h, and the level of NS3 protein was detected by WB. NS3 degradation was still observed in the MG132-treated group, whereas NH4Cl restored the decrease in NS3 level caused by S100A6 (Figures 7E, F). These results indicated that overexpression of S100A6 promoted NS3 protein degradation through the lysosomal pathway.
3.6 Host S100A6 interacted with NS3
Host S100A6 degraded ZIKV NS3 through the lysosomal pathway. We further investigated whether this degradation process was facilitated by the interaction between S100A6 and NS3. HeLa cells were infected with ZIKV following S100A6 overexpression, and the cells were lysed for Co-IP. WB results showed that S100A6 interacted with ZIKV NS3 (Figure 7G). Next, we used IFA to detect the co-localization of S100A6 and NS3 in cells. BHK-21 cells were transfected with S100A6-HA, infected with ZIKV, and stained with a fluorescent HA antibody (green) and NS3 antibody (red). Co-localization was indicated by yellow fluorescence. We observed co-localization of S100A6 and NS3 in the cytoplasm (Figure 7H). Therefore, we concluded that S100A6 co-localized and interacted with ZIKV NS3, inducing NS3 degradation through the lysosomal pathway.
4 Discussion
ZIKV can effectively infect and replicate in various cell types. However, because its small RNA genome encodes only 10 proteins, ZIKV is highly dependent on host factors for replication, RNA synthesis and assembly of viral particles (). ZIKV can promote or inhibit the expression of some host proteins involved in the process of its binding, entry and replication (; ). It co-localizes with host Hsp70 and promotes viral RNA production and viral particle release (). BiP interacts with viral envelope protein E and cellular alkaline phosphatase, thus promoting its infection (). Host protein S100A6 is involved in the regulation of multiple cellular processes and is upregulated in response to various stimuli (; ; ). In porcine alveolar macrophages infected by HP-PRRSV, S100A6 is significantly upregulated (). Haemophilus parasuis infection significantly increases the transcription levels of S100A4 and S100A6 genes in the lungs, spleen and lymph nodes of pigs (). Similarly, we found that ZIKV infection significantly promoted the expression of host protein S100A6 in a dose- and time-dependent manner. The S100 protein family can interact with various pathogenic proteins, influencing their infection and replication processes. For example, S100A6 inhibits hepatitis C virus replication by interacting directly with FKBP8/FKBP38 and regulating the NS5A-FKBP8/FKBP38 interaction ().
In Toxoplasma gondii infection, S100A6 interacts with surface antigen 1 (SAG1), promoting adhesion, invasion, and infection (). S100A9 significantly inhibits the replication of HP-PRRSV by interacting with the viral N protein (). In our study, we observed that ZIKV infection upregulated S100A6 expression, and S100A6 knockdown in HeLa cells led to increased viral replication. Conversely, overexpression of S100A6 significantly inhibited viral replication but did not affect the binding and entry of the virus.
ZIKV structural proteins and genomic RNA form viral particles, and non-structural (NS) proteins are necessary for viral RNA replication, particle assembly, and inhibition of the host’s antiviral innate immune response (). NS proteins play important roles in the life cycle of the virus and the pathogenesis of ZIKV. Among the non-structural proteins, NS3 is a multifunctional protein composed of an N-terminal protease domain and a C-terminal helicase domain, which is involved in the unwinding of double-stranded RNA and the cleavage of ZIKV polyprotein during viral replication. Due to the multiple roles of NS3 in the viral cycle, it has been one of the main targets for drug screening in recent years (; ). ZIKV infection can induce the expression of C19orf66 in cells, which interacts and co-localizes with ZIKV NS3, thereby inducing NS3 degradation through a lysosome-dependent pathway and inhibiting viral infection (). PARP12 interacts with ZIKV NS1 and NS3, mediating their degradation through the proteasome pathway, and inhibiting viral replication (). In our study, we found that the host protein S100A6 led to the degradation of ZIKV NS3, suggesting that its downregulation may be related to ZIKV pathogenicity. In addition, S100A6 interacted and co-localized with ZIKV NS3, forming a complex in the infected cells.
Proteins are mainly degraded by the ubiquitin-proteasome pathway or lysosomal pathway. The lysosome is a membrane-bound organelle in eukaryotic cells containing various hydrolases, breaks down endogenous and exogenous biomolecules, including proteins, nucleic acids, carbohydrates, lipids and cell debris (). It is essential for innate immune recognition, antigen presentation and pathogen elimination (). ZIKV NS3 can mediate the cleavage of the endoplasmic reticulum autophagy receptor FAM134B to inhibit autophagy to achieve effective viral replication and viral particle assembly (). In our study, the lysosomal acidification inhibitor NH4Cl treatment significantly inhibited S100A6-mediated NS3 degradation, indicating that S100A6 degraded ZIKV NS3 in a lysosomal-dependent manner, thus interfering with the life cycle of the virus and inhibiting viral replication. In human histiocytic lymphoma cells (U937), PKC-δ translocates to lysosomes, mediating the phosphorylation and activation of lysosomal acidic sphingomyelinase, and activates the lysosomal degradation pathway (). It is also reported that S100 protein and PKC are co-localized (). And NH4Cl is a weak base known to inhibit lysosomal hydrolases by reducing the acidification of the lysosomal compartment. Future studies should thus explore the interaction mechanisms of lysosome-related molecules with S100A6 in the degradation of ZIKV NS3 protein. We hypothesized that S100A6 may mediate the degradation of ZIKV NS3 by forming a complex with PKC or other enzymes, or through interacting with lysosome-associated molecules.
Due to the multiple cellular functions of S100A6, besides binding and degrading NS3, S100A6 may also indirectly affect ZIKV replication by regulating cytoskeleton proteins such as vimentin (), interacting with calcium cycle protein binding protein/Siah-1 interacting protein (CacyBP/SIP) (), and regulating tumor suppressor factor p53 and cyclin-dependent kinase (CDK) (), thereby regulating cell cycle, proliferation, apoptosis, migration and other cellular processes. Host factors are potential therapeutic targets for various viral infections (; ). Although the interaction between ZIKV and its host cell remains to be further explored, we found that ZIKV infection increased the expression of S100A6 in host cells, and S100A6 could significantly inhibit virus replication. S100A6 interacted with and co-localized with ZIKV NS3, and induced NS3 degradation through the lysosomal pathway.
In summary, S100A6 acts as a host restriction factor, exerting an antiviral effect against ZIKV by degrading NS3 through the lysosomal pathway. These findings advance our understanding of the molecular mechanisms underlying ZIKV pathogenesis and may guide the development of novel antiviral therapeutic targets.
5 Conclusion
ZIKV infection promoted the expression of host S100A6 protein, which in turn regulated ZIKV NS3 degradation through the lysosomal pathway, thereby inhibiting viral replication. Our study highlights the role of S100A6 in ZIKV infection, revealing a novel mechanism for host resistance to the virus. These findings enhance our understanding of the interaction between ZIKV and its host and provide a theoretical basis for further investigation into the virus’s pathogenic mechanisms.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Ethics statement
Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.
Author contributions
JP: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing. LZ: Conceptualization, Data curation, Funding acquisition, Methodology, Writing – review & editing. RL: Investigation, Methodology, Validation, Writing – review & editing. HP: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing. WZ: Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This research was supported by Key project of National Natural Science Foundation of China (82330072), National Natural Science Foundation of China (82272364, 81971954), Guangdong Provincial Natural Science Foundation (2023A1515011733, 2024A1515011327) to HJP, and National Natural Science Youth Foundation of China (32102693) to LJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2025.1602743/full#supplementary-material
References
1
AgrelliA.de MouraR. R.CrovellaS.BrandaoL. A. C. (2019). ZIKA virus entry mechanisms in human cells. Infect. Genet. Evol.69, 22–29. doi: 10.1016/j.meegid.2019.01.018
2
BaoL.OdellA. F.StephenS. L.WheatcroftS. B.WalkerJ. H.PonnambalamS. (2012). The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. FEBS J.279, 4576–4588. doi: 10.1111/febs.12044
3
BijiA.KhatunO.SwarajS.NarayanR.RajmaniR. S.SardarR.et al. (2021). Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples. EBioMedicine70, 103525. doi: 10.1016/j.ebiom.2021.103525
4
BrassA. L.HuangI. C.BenitaY.JohnS. P.KrishnanM. N.FeeleyE. M.et al. (2009). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell139, 1243–1254. doi: 10.1016/j.cell.2009.12.017
5
ChenH.XuC.JinQ.LiuZ. (2014). S100 protein family in human cancer. Am. J. Cancer Res.4, 89–115.
6
ChenJ.ChenZ.LiuM.QiuT.FengD.ZhaoC.et al. (2020). Placental alkaline phosphatase promotes Zika virus replication by stabilizing viral proteins through BIP. mBio11, e01716-20. doi: 10.1128/mBio.01716-20
7
DonatoR.CannonB. R.SorciG.RiuzziF.HsuK.WeberD. J.et al. (2013). Functions of S100 proteins. Curr. Mol. Med.13, 24–57. doi: 10.2174/156652413804486214
8
DonatoR.SorciG.GiambancoI. (2017). S100A6 protein: functional roles. Cell Mol. Life Sci.74, 2749–2760. doi: 10.1007/s00018-017-2526-9
9
FerrarisP.YsselH.MisseD. (2019). Zika virus infection: an update. Microbes Infect.21, 353–360. doi: 10.1016/j.micinf.2019.04.005
10
GonzalezL. L.GarrieK.TurnerM. D. (2020). Role of S100 proteins in health and disease. Biochim. Biophys. Acta Mol. Cell Res.1867, 118677. doi: 10.1016/j.bbamcr.2020.118677
11
HilgenfeldR.LeiJ.ZhangL. (2018). The structure of the zika virus protease, NS2B/NS3(pro). Adv. Exp. Med. Biol.1062, 131–145. doi: 10.1007/978-981-10-8727-1_10
12
LefrancF.DecaesteckerC.BrotchiJ.HeizmannC. W.DewitteO.KissR.et al. (2005). Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm. Neuropathol. Appl. Neurobiol.31, 649–660. doi: 10.1111/j.1365-2990.2005.00682.x
13
LennemannN. J.CoyneC. B. (2017). Dengue and Zika viruses subvert reticulophagy by NS2B3-mediated cleavage of FAM134B. Autophagy13, 322–332. doi: 10.1080/15548627.2016.1265192
14
LesniakW.WilanowskiT.FilipekA. (2017). S100A6 - focus on recent developments. Biol. Chem.398, 1087–1094. doi: 10.1515/hsz-2017-0125
15
LiH.Saucedo-CuevasL.ShrestaS.GleesonJ. G. (2016). The neurobiology of zika virus. Neuron92, 949–958. doi: 10.1016/j.neuron.2016.11.031
16
LiL.ZhaoH.LiuP.LiC.QuanquinN.JiX.et al. (2018). PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins. Sci. Signal11, eaas9332. doi: 10.1126/scisignal.aas9332
17
MarceauC. D.PuschnikA. S.MajzoubK.OoiY. S.BrewerS. M.FuchsG.et al. (2016). Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens. Nature535, 159–163. doi: 10.1038/nature18631
18
NagyP. D.PoganyJ. (2011). The dependence of viral RNA replication on co-opted host factors. Nat. Rev. Microbiol.10, 137–149. doi: 10.1038/nrmicro2692
19
ParentN.SchererM.LiebischG.SchmitzG.BertrandR. (2011). Protein kinase C-delta isoform mediates lysosome labilization in DNA damage-induced apoptosis. Int. J. Oncol.38, 313–324. doi: 10.3892/ijo.2010.881
20
PielnaaP.Al-SaadaweM.SaroA.DamaM. F.ZhouM.HuangY.et al. (2020). Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology543, 34–42. doi: 10.1016/j.virol.2020.01.015
21
PiersonT. C.DiamondM. S. (2018). The emergence of Zika virus and its new clinical syndromes. Nature560, 573–581. doi: 10.1038/s41586-018-0446-y
22
PujhariS.BrustolinM.MaciasV. M.NisslyR. H.NomuraM.KuchipudiS. V.et al. (2019). Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells. Emerg. Microbes Infect.8, 8–16. doi: 10.1080/22221751.2018.1557988
23
SaftigP.KlumpermanJ. (2009). Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol.10, 623–635. doi: 10.1038/nrm2745
24
ShimizuY.FujishiroH.MatsumotoK.SumiD.SatohM.HimenoS. (2011). Chronic exposure to arsenite induces S100A8 and S100A9 expression in rat RBL-2H3 mast cells. J. Toxicol. Sci.36, 135–139. doi: 10.2131/jts.36.135
25
SirohiD.KuhnR. J. (2017). Zika virus structure, maturation, and receptors. J. Infect. Dis.216, S935–S944. doi: 10.1093/infdis/jix515
26
SongZ.BaiJ.LiuX.NauwynckH.WuJ.LiuX.et al. (2019). S100A9 regulates porcine reproductive and respiratory syndrome virus replication by interacting with the viral nucleocapsid protein. Vet. Microbiol.239, 108498. doi: 10.1016/j.vetmic.2019.108498
27
SongD.XuB.ShiD.LiS.CaiY. (2020). S100A6 promotes proliferation and migration of HepG2 cells via increased ubiquitin-dependent degradation of p53. Open Med. (Wars)15, 317–326. doi: 10.1515/med-2020-0101
28
SpenceJ. S.HeR.HoffmannH. H.DasT.ThinonE.RiceC. M.et al. (2019). IFITM3 directly engages and shuttles incoming virus particles to lysosomes. Nat. Chem. Biol.15, 259–268. doi: 10.1038/s41589-018-0213-2
29
TamaiH.MiyakeK.YamaguchiH.TakatoriM.DanK.InokuchiK.et al. (2011). Resistance of MLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosis factor-alpha is mediated by S100A6 upregulation. Blood Cancer J.1, e38. doi: 10.1038/bcj.2011.37
30
TaniJ.ShimamotoS.MoriK.KatoN.MoriishiK.MatsuuraY.et al. (2013). Ca(2+)/S100 proteins regulate HCV virus NS5A-FKBP8/FKBP38 interaction and HCV virus RNA replication. Liver Int.33, 1008–1018. doi: 10.1111/liv.12151
31
TayM. Y. F.VasudevanS. G. (2018). The transactions of NS3 and NS5 in flaviviral RNA replication. Adv. Exp. Med. Biol.1062, 147–163. doi: 10.1007/978-981-10-8727-1_11
32
VictoraC. G.Schuler-FacciniL.MatijasevichA.RibeiroE.PessoaA.BarrosF. C. (2016). Microcephaly in Brazil: how to interpret reported numbers? Lancet387, 621–624. doi: 10.1016/S0140-6736(16)00273-7
33
WangT.HanS.DuG. (2021). S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis. Cell Biochem. Funct.39, 771–779. doi: 10.1002/cbf.3639
34
WangY.KangX.KangX.YangF. (2023). S100A6: molecular function and biomarker role. biomark. Res.11, 78. doi: 10.1186/s40364-023-00515-3
35
WangY.LingL.ZhangZ.Marin-LopezA. (2022). Current advances in zika vaccine development. Vaccines (Basel)10, 1816. doi: 10.3390/vaccines10111816
36
WangY.LiuC.FangY.LiuX.LiW.LiuS.et al. (2012). Transcription analysis on response of porcine alveolar macrophages to Haemophilus parasuis. BMC Genomics13, 68. doi: 10.1186/1471-2164-13-68
37
WhiteM. K.WolleboH. S.David BeckhamJ.TylerK. L.KhaliliK. (2016). Zika virus: An emergent neuropathological agent. Ann. Neurol.80, 479–489. doi: 10.1002/ana.24748
38
WuY.YangX.YaoZ.DongX.ZhangD.HuY.et al. (2020). C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3. PloS Negl. Trop. Dis.14, e0008083. doi: 10.1371/journal.pntd.0008083
39
XingH.XuS.JiaF.YangY.XuC.QinC.et al. (2020). Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity. Virus Res.275, 197793. doi: 10.1016/j.virusres.2019.197793
40
YangW.WuY. H.LiuS. Q.ShengZ. Y.ZhenZ. D.GaoR. Q.et al. (2020). S100A4+ macrophages facilitate zika virus invasion and persistence in the seminiferous tubules via interferon-gamma mediation. PloS Pathog.16, e1009019. doi: 10.1371/journal.ppat.1009019
41
ZhangR.MinerJ. J.GormanM. J.RauschK.RamageH.WhiteJ. P.et al. (2016). A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature535, 164–168. doi: 10.1038/nature18625
42
ZhangY.ZhaoS.LiY.FengF.LiM.XueY.et al. (2022). Host cytoskeletal vimentin serves as a structural organizer and an RNA-binding protein regulator to facilitate Zika viral replication. Proc. Natl. Acad. Sci. U.S.A.119, e2113909119. doi: 10.1073/pnas.2113909119
43
ZhouJ.ChiX.ChengM.HuangX.LiuX.FanJ.et al. (2019). Zika virus degrades the omega-3 fatty acid transporter Mfsd2a in brain microvascular endothelial cells and impairs lipid homeostasis. Sci. Adv.5, eaax7142. doi: 10.1126/sciadv.aax7142
44
ZhouL. J.PengJ.ChenM.YaoL. J.ZouW. H.HeC. Y.et al. (2021). Toxoplasma gondii SAG1 targeting host cell S100A6 for parasite invasion and host immunity. iScience24, 103514. doi: 10.1016/j.isci.2021.103514
45
ZhouX.WangP.MichalJ. J.WangY.ZhaoJ.JiangZ.et al. (2015). Molecular characterization of the porcine S100A6 gene and analysis of its expression in pigs infected with highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV). J. Appl. Genet.56, 355–363. doi: 10.1007/s13353-014-0260-7
Summary
Keywords
Zika virus, S100 calcium binding protein A6, NS3 protein, virus replication, lysosomes
Citation
Peng J, Zou W, Zhou L, Liu R and Peng H-J (2025) Host S100A6 inhibits ZIKV replication by degrading NS3 through lysosomal pathway. Front. Cell. Infect. Microbiol. 15:1602743. doi: 10.3389/fcimb.2025.1602743
Received
30 March 2025
Accepted
12 September 2025
Published
01 October 2025
Volume
15 - 2025
Edited by
Shelton S Bradrick, Trudeau Institute, United States
Reviewed by
Adam T Fishburn, University of California, Davis, United States
Shulong Zu, Tianjin Medical University, China
Updates
Copyright
© 2025 Peng, Zou, Zhou, Liu and Peng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hong-Juan Peng, floriapeng@hotmail.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.